Back
ProShares UltraPro S&P500 Vs. Verona Pharma PLC Industry Stock Comparison
Sell
40
UPRO
ProShares UltraPro S&P500
Last Price:
$95.91
Seasonality Move:
10.28%
Sell
48
VRNA
Verona Pharma PLC
Last Price:
$45.02
Seasonality Move:
1.28%
Sell
40
ProShares UltraPro S&P500 (UPRO)
is a Sell
Is ProShares UltraPro S&P500 a Buy, Sell or Hold?
-
The current ProShares UltraPro S&P500 [UPRO] share price is $91.48. The Score for UPRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
UPRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Verona Pharma PLC (VRNA)
is a Sell
Is Verona Pharma PLC a Buy, Sell or Hold?
-
The current Verona Pharma PLC [VRNA] share price is $45.28. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
VRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UPRO Stock Price Chart
What is ProShares UltraPro S&P500's stock price today?
-
The ProShares UltraPro S&P500 share price today is $91.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPRO is experiencing slight buying pressure.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $45.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
UPRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 43.54 | Sell |
| Chaikin Money Flow: | 2410861 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.79 - 98.73) | Sell |
| Bollinger Bands (100): | (77.34 - 94.26) | Buy |
VRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.47 | Buy |
| Relative Strength Index (14 RSI): | 69.35 | Buy |
| Chaikin Money Flow: | 672029 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.1 - 41.82) | Buy |
| Bollinger Bands (100): | (26.7 - 38.58) | Buy |
UPRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.88 | Sell |
| 20-day SMA: | 96.23 | Sell |
| 50-day SMA: | 92.45 | Sell |
| 200-day SMA: | 78.62 | Buy |
| 8-day EMA: | 93.59 | Sell |
| 20-day EMA: | 94.73 | Sell |
| 50-day EMA: | 92.19 | Sell |
| 200-day EMA: | 79.38 | Buy |
VRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.71 | Buy |
| 20-day SMA: | 40.52 | Buy |
| 50-day SMA: | 37.79 | Buy |
| 200-day SMA: | 24.36 | Buy |
| 8-day EMA: | 42.01 | Buy |
| 20-day EMA: | 40.56 | Buy |
| 50-day EMA: | 37.61 | Buy |
| 200-day EMA: | 27.82 | Buy |
ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.
ProShares UltraPro S&P500 Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verona Pharma PLC Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||